---
figid: PMC10907749__12276_2024_1165_Fig4_HTML
figtitle: T. gondii antigen alters the signaling pathway of the host cell
organisms:
- NA
organisms_ner:
- Homo sapiens
pmcid: PMC10907749
filename: 12276_2024_1165_Fig4_HTML.jpg
figlink: /pmc/articles/PMC10907749/figure/F4
number: F4
caption: T. gondii antigens, including MICs, ROPs, GRAs, and SAGs, manipulate host
  cell signaling pathways. a In DCs, STAg induces the expression of SOCS2 via LXA4
  and consequently suppresses IL-2 expression and CCR5 secretion. ROP5 and ROP18 suppress
  MHC I antigen presentation by resisting IFN-γ and IRG. b In macrophages, MIC1 and
  MIC4 bind to TLR4; induce the secretion of IL-12, TNF-α, and IL-6 through NF-κB;
  and translocate TLR4 to endosomes to produce the anti-inflammatory cytokine IL-10.
  SAG-1 and SAG-2 induce IL-1/IL-6/GM-CSF/TNF-α transcription in macrophages. GRA9
  disrupts NLRP3 inflammasome assembly by blocking the binding of ASC to NLRP3 and
  consequently suppressing IL-1β and IL-18 secretion. ROP5, ROP18, and GRA7 inhibit
  MHC I antigen presentation by resisting IFN-γ and IRG. ROP16 activates STAT3- and
  STAT6-dependent M2 macrophages and induces the expression of the M2 macrophage marker
  Arg-1 and the secretion of IL-1 and IL-1ra
papertitle: Exploring the potential of Toxoplasma gondii in drug development and as
  a delivery system
reftext: Chanjin Yoon, et al. Exp Mol Med. 2024 Feb;56(2).
year: '2024'
doi: 10.1038/s12276-024-01165-7
journal_title: Experimental & Molecular Medicine
journal_nlm_ta: Exp Mol Med
publisher_name: Nature Publishing Group UK
keywords: Parasitic infection | Mechanisms of disease
automl_pathway: 0.8554687
figid_alias: PMC10907749__F4
figtype: Figure
redirect_from: /figures/PMC10907749__F4
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC10907749__12276_2024_1165_Fig4_HTML.html
  '@type': Dataset
  description: T. gondii antigens, including MICs, ROPs, GRAs, and SAGs, manipulate
    host cell signaling pathways. a In DCs, STAg induces the expression of SOCS2 via
    LXA4 and consequently suppresses IL-2 expression and CCR5 secretion. ROP5 and
    ROP18 suppress MHC I antigen presentation by resisting IFN-γ and IRG. b In macrophages,
    MIC1 and MIC4 bind to TLR4; induce the secretion of IL-12, TNF-α, and IL-6 through
    NF-κB; and translocate TLR4 to endosomes to produce the anti-inflammatory cytokine
    IL-10. SAG-1 and SAG-2 induce IL-1/IL-6/GM-CSF/TNF-α transcription in macrophages.
    GRA9 disrupts NLRP3 inflammasome assembly by blocking the binding of ASC to NLRP3
    and consequently suppressing IL-1β and IL-18 secretion. ROP5, ROP18, and GRA7
    inhibit MHC I antigen presentation by resisting IFN-γ and IRG. ROP16 activates
    STAT3- and STAT6-dependent M2 macrophages and induces the expression of the M2
    macrophage marker Arg-1 and the secretion of IL-1 and IL-1ra
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - IL2
  - STAG1
  - STAG2
  - STAG3
  - CCR5
  - IFNG
  - SOCS2
  - CD44
  - GDF15
  - RMC1
  - TLR4
  - NFKB1
  - HLA-C
  - IL10
  - IL1B
  - IL6
  - CSF2
  - LAMC2
  - TNF
  - IL12A
  - IL12B
  - IL1A
  - IL18
  - NLRP3
  - STAT6
  - STAT3
  - STS
  - PYCARD
  - ARG1
  - TINAGL1
  - IL1RN
  - IL6R
  - LXA4
---
